BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18406867)

  • 1. Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays.
    Argos M; Kibriya MG; Jasmine F; Olopade OI; Su T; Hibshoosh H; Ahsan H
    Cancer Genet Cytogenet; 2008 Apr; 182(2):69-74. PubMed ID: 18406867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.
    Toma MI; Grosser M; Herr A; Aust DE; Meye A; Hoefling C; Fuessel S; Wuttig D; Wirth MP; Baretton GB
    Neoplasia; 2008 Jul; 10(7):634-42. PubMed ID: 18592004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
    Marescalco MS; Capizzi C; Condorelli DF; Barresi V
    J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
    Hawthorn L; Luce J; Stein L; Rothschild J
    BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.
    Beroukhim R; Lin M; Park Y; Hao K; Zhao X; Garraway LA; Fox EA; Hochberg EP; Mellinghoff IK; Hofer MD; Descazeaud A; Rubin MA; Meyerson M; Wong WH; Sellers WR; Li C
    PLoS Comput Biol; 2006 May; 2(5):e41. PubMed ID: 16699594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array.
    Ching HC; Naidu R; Seong MK; Har YC; Taib NA
    Int J Oncol; 2011 Sep; 39(3):621-33. PubMed ID: 21687935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array.
    Hu N; Wang C; Hu Y; Yang HH; Kong LH; Lu N; Su H; Wang QH; Goldstein AM; Buetow KH; Emmert-Buck MR; Taylor PR; Lee MP
    BMC Genomics; 2006 Nov; 7():299. PubMed ID: 17134496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
    George RE; Attiyeh EF; Li S; Moreau LA; Neuberg D; Li C; Fox EA; Meyerson M; Diller L; Fortina P; Look AT; Maris JM
    PLoS One; 2007 Feb; 2(2):e255. PubMed ID: 17327916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers.
    Wang ZC; Lin M; Wei LJ; Li C; Miron A; Lodeiro G; Harris L; Ramaswamy S; Tanenbaum DM; Meyerson M; Iglehart JD; Richardson A
    Cancer Res; 2004 Jan; 64(1):64-71. PubMed ID: 14729609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analysis of loss of heterozygosity and copy number amplification in uterine leiomyomas using the 100K single nucleotide polymorphism array.
    Meadows KL; Andrews DM; Xu Z; Carswell GK; Laughlin SK; Baird DD; Taylor JA
    Exp Mol Pathol; 2011 Aug; 91(1):434-9. PubMed ID: 21497600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
    Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
    Hu N; Clifford RJ; Yang HH; Wang C; Goldstein AM; Ding T; Taylor PR; Lee MP
    BMC Genomics; 2010 Oct; 11():576. PubMed ID: 20955586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis.
    Fang M; Toher J; Morgan M; Davison J; Tannenbaum S; Claffey K
    Cancer; 2011 May; 117(10):2024-34. PubMed ID: 21523713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
    Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
    BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonparametric estimation of LOH using Affymetrix SNP genotyping arrays for unpaired samples.
    Huggins R; Li LH; Lin YC; Yu AL; Yang HC
    J Hum Genet; 2008; 53(11-12):983-990. PubMed ID: 18989737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the FAM5C in tongue squamous cell carcinoma.
    Kuroiwa T; Yamamoto N; Onda T; Shibahara T
    Oncol Rep; 2009 Nov; 22(5):1005-11. PubMed ID: 19787213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.